organization · Reporting owner
Ever Alpha Fund L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | 10% owner | November 02, 2018 | November 06, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date November 02, 2018 · Filed November 06, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,294,961 |
Reported balance
After 2018-11-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-11-02 · Conversion · Acquired 3,294,961 · Balance 3,294,961 F1: The Series D Preferred Stock has no expiration date and will convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2: Ever Glory Limited is the general partner of Ever Alpha Fund L.P. Ever Glory Limited is a wholly owned subsidiary of Guangfa Xinde Capital Management Limited. Guangfa Xinde Capital Management Limited is a wholly owned subsidiary of Guangfa Investment (Hong Kong) Company Limited. Guangfa Investment (Hong Kong) Company Limited is a wholly owned subsidiary of Guangfa Holding (Hong Kong) Corporation Limited. |
| Series D Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-11-02 · Conversion · Disposed 3,294,961 · Balance 0 F1: The Series D Preferred Stock has no expiration date and will convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2: Ever Glory Limited is the general partner of Ever Alpha Fund L.P. Ever Glory Limited is a wholly owned subsidiary of Guangfa Xinde Capital Management Limited. Guangfa Xinde Capital Management Limited is a wholly owned subsidiary of Guangfa Investment (Hong Kong) Company Limited. Guangfa Investment (Hong Kong) Company Limited is a wholly owned subsidiary of Guangfa Holding (Hong Kong) Corporation Limited. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series D Preferred Stock has no expiration date and will convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering.
F2: Ever Glory Limited is the general partner of Ever Alpha Fund L.P. Ever Glory Limited is a wholly owned subsidiary of Guangfa Xinde Capital Management Limited. Guangfa Xinde Capital Management Limited is a wholly owned subsidiary of Guangfa Investment (Hong Kong) Company Limited. Guangfa Investment (Hong Kong) Company Limited is a wholly owned subsidiary of Guangfa Holding (Hong Kong) Corporation Limited.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2018 Filed Nov 6, 2018 17:02 UTC | Twist Bioscience Corp TWST · Entity 3619 | ConversionSeries D Preferred Stock · Derivative | 3,294,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-057433 · doc4.xml · derivative · entry 2 Ever Alpha Fund L.P. · CIK 0001757411 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,294,961 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series D Preferred Stock has no expiration date and will convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: The Series D Preferred Stock has no expiration date and will convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: The Series D Preferred Stock has no expiration date and will convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2 · ownership.direct: Ever Glory Limited is the general partner of Ever Alpha Fund L.P. Ever Glory Limited is a wholly owned subsidiary of Guangfa Xinde Capital Management Limited. Guangfa Xinde Capital Management Limited is a wholly owned subsidiary of Guangfa Investment (Hong Kong) Company Limited. Guangfa Investment (Hong Kong) Company Limited is a wholly owned subsidiary of Guangfa Holding (Hong Kong) Corporation Limited. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 17:02 UTC | Twist Bioscience Corp TWST · Entity 3619 | ConversionCommon Stock | 3,294,961 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-057433 · doc4.xml · nonDerivative · entry 1 Ever Alpha Fund L.P. · CIK 0001757411 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,294,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series D Preferred Stock has no expiration date and will convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2 · ownership.direct: Ever Glory Limited is the general partner of Ever Alpha Fund L.P. Ever Glory Limited is a wholly owned subsidiary of Guangfa Xinde Capital Management Limited. Guangfa Xinde Capital Management Limited is a wholly owned subsidiary of Guangfa Investment (Hong Kong) Company Limited. Guangfa Investment (Hong Kong) Company Limited is a wholly owned subsidiary of Guangfa Holding (Hong Kong) Corporation Limited. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.